Navigation Links
Accuray Receives 510(k) Clearance for a Rotational Dose Control for the TomoTherapy System
Date:10/25/2011

SUNNYVALE, Calif., Oct. 25, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market the Dose Control System (DCS), a new feature for Accuray's TomoTherapy® System that improves system performance.  

The TomoTherapy System revolutionized radiation therapy with the introduction of helical delivery, providing precise application of dose to target structures while sparing healthy tissue. With the advent of the Dose Control System the TomoTherapy System again breaks new ground as the first dose servo-controlled helical delivery system (patent pending). This approach provides even higher precision with unprecedented dose stability throughout complex rotational treatments. Static delivery provided by the TomoDirect™ option also benefits from a more stable and consistent dose rate at every gantry angle.  

The new DCS feature provides these gains by automatically adjusting controls previously handled through a manual process. This means small variations in dose rate are immediately corrected by the system, resulting in fewer interruptions. The DCS application also ensures a more stable output over longer duration treatments, such as Total Marrow and Total Body Irradiation. The result of this new product feature is higher customer satisfaction, a better patient experience, and improved overall system performance.

"FDA clearance of the new Dose Control System is a positive step toward improving TomoTherapy System performance and customer satisfaction," said Euan S. Thomson, Ph.D., president and chief executive officer of Accuray. "We are dedicated to offering our customers technological advancements that help streamline their workflow and expand the cap
'/>"/>

SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2012
2. Accuray Ranked 274th Fastest Growing Company in North America on Deloittes 2011 Technology Fast 500™
3. Accuray Unveils CyberKnife and TomoTherapy Product Enhancements and Service Offerings at ASTRO 2011
4. Accuray Incorporated to Speak at JMP Securities Healthcare Conference
5. Accuray Hires Chief Commercial Officer
6. Accuray Announces Results for Fourth Quarter and Fiscal Year 2011
7. Accuray Incorporated to Speak at UBS Global Life Sciences Conference
8. Accuray Extends Industry-Leading Customer Service Program to TomoTherapy Systems
9. Accuray Launches New Organization for CyberKnife® and TomoTherapy® System Users
10. Accuray Drives Growth in Radiosurgery for Early-Stage Prostate Cancer
11. Accuray Incorporated to Host Investor Meeting at ASTRO 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... and PHOENIX , Aug. ... to bring cutting-edge next-generation sequencing and proteomic diagnostics ... today announced a collaboration with TESARO, Inc.  Paradigm ... patient tissue samples from clinical trials to better ... to TESARO,s TSR-011.  This may lead to more successful ...
(Date:8/20/2014)... ApolloDx™ today announced it will unveil and ... event at the company,s office in Salt ... The event, which will start at 10:00 a.m., will ... .    "We believe our mobile diagnostic ... , Co-Founder and Managing Partner of ApolloDx. In addition ...
(Date:8/20/2014)... WORTH, Fla. , Aug. 20, 2014  Glades Drugs, ... , is proud to announce its expansion into a ... , which will feature an 8,000-square-foot office space and state ... currently accepting applications for 100 open positions for the new ... at 4560 Lantana Road will serve as the chain,s corporate ...
Breaking Medicine Technology:Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2
... COGENT-1 Study of CGT-2168 Expands to Europe; Focus ... Gastrointestinal Side Effects of Antiplatelet Therapy, ... Pharmaceuticals,Inc. today announced that the first patient has ... 3 study of its novel combination medicine,CGT-2168. The ...
... Motion Technologies,announced the completion of the first surgical ... System (TM) (TSMS(TM)), the first total,joint replacement system ... and posterior dynamic stabilization device (PDS). The,successful procedure ... Numune,Education and Training Hospital by Dr. Erkan Kaptanoglu, ...
Cached Medicine Technology:European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals 2Disc Motion Technologies Announces First Human Implants of True TSMS(TM) Device 2
(Date:8/20/2014)... 20, 2014 Caddis Partners LLC, has ... any healthcare real estate company in recent years, developing ... valued at $500 million, including more than $100 million ... growth, including expansions into new geographic regions and a ... executives are pleased to announce an enhanced brand identity ...
(Date:8/20/2014)... Biocide Systems is proud to ... as a consultant and partner for a host ... As Wrench Advisors explains on its website, “Our ... plan and execute programs by leveraging Wrench’s access ... experience developing joint venture partnerships and arranging strategic ...
(Date:8/20/2014)... TX (PRWEB) August 20, 2014 The ... Surgery (ACPS), has expanded its presence throughout Houston to ... Mann Eye Institute and Laser Center building. ACPS plastic ... natural step forward for ACPS, which has risen to ... plastic surgery practices in the state since its establishment ...
(Date:8/20/2014)... -- White, straight women are much more likely to ... women, a new study finds. Researchers examined data ... 44, who took part in polls in 2002 and ... Family Growth study. In the first poll, 13 ... for infertility. This ranged from getting advice from doctors ...
(Date:8/20/2014)... survey of U.S. veterans receiving mental health services from ... significant room for improvement among all areas studied. , ... found that patients with a substance use disorder were ... services. Those with substance abuse problems also were less ... them or respected their decisions. , The findings, published ...
Breaking Medicine News(10 mins):Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 2Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 3Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 4Health News:Biocide Systems Announces Partnership with Wrench Advisors 2Health News:Aesthetic Center for Plastic Surgery Expands Its Reach in Texas 2Health News:White Women More Likely to Seek Fertility Treatment: Report 2Health News:Survey finds veterans generally satisfied with mental health care 2
... will present study results that indicate that subconjunctivally delivered ... rat retinas at the Association for Research in Vision ... Fla. The presentation will take place on Thursday, May ... B/C of the Greater Fort Lauderdale/Broward County Convention Center. ...
... to uncover the medium- and large-scale genetic differences between humans ... wide range of diseases, according to a paper by Howard ... in the May 10, 2007, Nature. The undertaking will help ... amount to as much as five to ten percent of ...
... striking similarities between the immune systems of humans and ... could also lead to breakthroughs in the understanding and ... marsupials now found only in the Australian island state ... compiled the full set of genetic information of the ...
... US children undergo some trauma or other early ... post-traumatic stress disorder. ,The finding reveals ... suggests that the way children process troubling experiences is ... Medical Center, whose study appeared in the Archives of ...
... Investigators at St. Jude Children's Research Hospital had a ... kit as it assembled on a double-strand break ... ruptures that cut completely across the twisted, ladder-like structure ... ,Using a technique developed specifically for this project, the ...
... (HCV) are at an increased risk of developing certain ... study published in the May 8, 2007, issue ... from the National Cancer Institute (NCI), part of the ... found that HCV infection increased the risk of developing ...
Cached Medicine News:Health News:Cataloging the Structural Variations in Human Genetics 2Health News:Cataloging the Structural Variations in Human Genetics 3Health News:Treatment of Premature Babies, Opossums Could Help 2Health News:Two-thirds of US Children Experience Trauma, but Recover Fast 2Health News:DNA Repair Proteins Monitored at Double-strand Break 2Health News:Risk of Lymphoma Increases With Hepatitis C Virus Infection 2
0.2 mm hook with curved shaft to reach over lens optic. Flat serrated handle with polished finish. Overall length: 4.8 inches. Most popular size or model....
0.3 mm hook angled 45 degrees, 9 mm from tip to bend. Flat smooth handle with polished finish. Overall length: 4.6 inches....
2.0 mm cup. Angled 45 degree shaft 8 mm from tip to bend with flat handle and polished finish. Overall length: 4.8 inches....
Round, knurled handle with polished finish and straight shaft. 1 mm ring curette 1.5 mm high, 33 mm shaft. Overall length: 5.1 inches....
Medicine Products: